|
|
||||||||
B Activation in Collagen-Induced Arthritis1



Departments of
*
Medicine/Rheumatology and Cell Biology and
Microbiology and Immunology, Vanderbilt University, Nashville, TN 37232; and
Department of Pharmacology, Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT 06877
NF-
B/Rel proteins are ubiquitous transcription factors that are
activated by proinflammatory signals or engagement of Ag receptors. To
study the role of NF-
B/Rel signaling in T lymphocytes during
autoimmune disease, we investigated type II collagen-induced arthritis
(CIA) in transgenic mice expressing a constitutive inhibitor of
NF-
B/Rel (I
B
(
N)) in the T lineage. Expression of the
I
B
(
N) transgene was persistently high in adult peripheral
lymphoid organs and undetectable in T cell-depleted splenocytes,
suggesting the expression of the transgene is restricted to the T
lineage. The incidence and severity of CIA were decreased significantly
in these I
B
(
N) transgenic mice compared with nontransgenic
littermates. Inhibition of CIA was not due solely to a decrease in
their CD8+ population because transfer of wild-type
CD8+ cells into transgenic mice failed to restore disease
susceptibility. Protection against disease was associated with a
moderate decrease in clonal expansion and a profound and persistent
decrease in Ag-induced IFN-
production in vivo. Consistent with
decreased level of anti-type II collagen-specific Abs and IFN-
,
serum levels of IgG2a anti-CII Abs were significantly reduced.
However, anti-CII-specific IgG1 levels were normal, indicating that
some aspects of T cell help were unaffected. Taken together, these
results suggest that inhibition of NF-
B in T cells impairs CIA
development in vivo through decreases in type 1 T cell-dependent
responses.
This article has been cited by other articles:
![]() |
A. Fontalba, V. Martinez-Taboada, O. Gutierrez, C. Pipaon, N. Benito, A. Balsa, R. Blanco, and J. L. Fernandez-Luna Deficiency of the NF-{kappa}B Inhibitor Caspase Activating and Recruitment Domain 8 in Patients with Rheumatoid Arthritis Is Associated with Disease Severity J. Immunol., October 1, 2007; 179(7): 4867 - 4873. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Xu, Y. He, X. Yang, L. Liang, Z. Zhan, Y. Ye, X. Yang, F. Lian, and L. Sun Anti-malarial agent artesunate inhibits TNF-{alpha}-induced production of proinflammatory cytokines via inhibition of NF-{kappa}B and PI3 kinase/Akt signal pathway in human rheumatoid arthritis fibroblast-like synoviocytes Rheumatology, June 1, 2007; 46(6): 920 - 926. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, A. L. Mora, J. LaVoy, K. L. Brigham, and M. Rojas Increased bleomycin-induced lung injury in mice deficient in the transcription factor T-bet Am J Physiol Lung Cell Mol Physiol, October 1, 2006; 291(4): L658 - L667. [Abstract] [Full Text] [PDF] |
||||
![]() |
M G Ruocco and M Karin IKK{beta} as a target for treatment of inflammation induced bone loss Ann Rheum Dis, November 1, 2005; 64(suppl_4): iv81 - iv85. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. L. Mora, J. LaVoy, M. McKean, A. Stecenko, K. L. Brigham, R. Parker, and M. Rojas Prevention of NF-{kappa}B activation in vivo by a cell-permeable NF-{kappa}B inhibitor peptide Am J Physiol Lung Cell Mol Physiol, October 1, 2005; 289(4): L536 - L544. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Saika, T. Miyamoto, O. Yamanaka, T. Kato, Y. Ohnishi, K. C. Flanders, K. Ikeda, Y. Nakajima, W. W.-Y. Kao, M. Sato, et al. Therapeutic Effect of Topical Administration of SN50, an Inhibitor of Nuclear Factor-{kappa}B, in Treatment of Corneal Alkali Burns in Mice Am. J. Pathol., May 1, 2005; 166(5): 1393 - 1403. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Podolin, J. F. Callahan, B. J. Bolognese, Y. H. Li, K. Carlson, T. G. Davis, G. W. Mellor, C. Evans, and A. K. Roshak Attenuation of Murine Collagen-Induced Arthritis by a Novel, Potent, Selective Small Molecule Inhibitor of I{kappa}B Kinase 2, TPCA-1 (2-[(Aminocarbonyl)amino]-5-(4-fluorophenyl)-3-thiophenecarboxamide), Occurs via Reduction of Proinflammatory Cytokines and Antigen-Induced T Cell Proliferation J. Pharmacol. Exp. Ther., January 1, 2005; 312(1): 373 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. H. J. Remans, S. I. Gringhuis, J. M. van Laar, M. E. Sanders, E. A. M. Papendrecht-van der Voort, F. J. T. Zwartkruis, E. W. N. Levarht, M. Rosas, P. J. Coffer, F. C. Breedveld, et al. Rap1 Signaling Is Required for Suppression of Ras-Generated Reactive Oxygen Species and Protection Against Oxidative Stress in T Lymphocytes J. Immunol., July 15, 2004; 173(2): 920 - 931. [Abstract] [Full Text] [PDF] |
||||
![]() |
D Hammaker, S Sweeney, and G S Firestein Signal transduction networks in rheumatoid arthritis Ann Rheum Dis, November 1, 2003; 62(90002): ii86 - 89. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Corn, M. A. Aronica, F. Zhang, Y. Tong, S. A. Stanley, S. R. A. Kim, L. Stephenson, B. Enerson, S. McCarthy, A. Mora, et al. T Cell-Intrinsic Requirement for NF-{kappa}B Induction in Postdifferentiation IFN-{gamma} Production and Clonal Expansion in a Th1 Response J. Immunol., August 15, 2003; 171(4): 1816 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. Eriksson, M. O. Kurrer, I. Sonderegger, G. Iezzi, A. Tafuri, L. Hunziker, S. Suzuki, K. Bachmaier, R. M. Bingisser, J. M. Penninger, et al. Activation of Dendritic Cells through the Interleukin 1 Receptor 1 Is Critical for the Induction of Autoimmune Myocarditis J. Exp. Med., February 3, 2003; 197(3): 323 - 331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Caamano and C. A. Hunter NF-{kappa}B Family of Transcription Factors: Central Regulators of Innate and Adaptive Immune Functions Clin. Microbiol. Rev., July 1, 2002; 15(3): 414 - 429. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Wagner Jr., G. Vaitaitis, R. Sanderson, M. Poulin, C. Dobbs, and K. Haskins Expression of CD40 identifies a unique pathogenic T cell population in type 1 diabetes PNAS, March 19, 2002; 99(6): 3782 - 3787. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. W. Finn, J. R. Stone, M. R. Boothby, and D. L. Perkins Inhibition of NF-{kappa}B-Dependent T Cell Activation Abrogates Acute Allograft Rejection J. Immunol., November 15, 2001; 167(10): 5994 - 6001. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Abad, C. Martinez, J. Leceta, R. P. Gomariz, and M. Delgado Pituitary Adenylate Cyclase-Activating Polypeptide Inhibits Collagen-Induced Arthritis: An Experimental Immunomodulatory Therapy J. Immunol., September 15, 2001; 167(6): 3182 - 3189. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Chen, E. Rosloniec, M. I. Goral, M. Boothby, and J. Chen Redirection of T Cell Effector Function In Vivo and Enhanced Collagen-Induced Arthritis Mediated by an IL-2R{{beta}}/IL-4R{{alpha}} Chimeric Cytokine Receptor Transgene J. Immunol., March 15, 2001; 166(6): 4163 - 4169. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Gerlag, L. Ransone, P. P. Tak, Z. Han, M. Palanki, M. S. Barbosa, D. Boyle, A. M. Manning, and G. S. Firestein The Effect of a T Cell-Specific NF-{kappa}B Inhibitor on In Vitro Cytokine Production and Collagen-Induced Arthritis J. Immunol., August 1, 2000; 165(3): 1652 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Song, Y. Chen, R. Goke, A. Wilmen, C. Seidel, A. Goke, B. Hilliard, and Y. Chen Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (Trail) Is an Inhibitor of Autoimmune Inflammation and Cell Cycle Progression J. Exp. Med., April 3, 2000; 191(7): 1095 - 1104. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |